In this issue:
- Outpatient intravenous diuretics for worsening HF
Comparison of HF risk scores for predicting mortality and re-admission - Prognosis of transthyretin cardiac amyloidosis without HF symptoms
- ARNI prescription at hospital discharge in HFREF
- CV complications of ICIs
- ASP and HF progression in ARVC
- Treatment response in recentonset nonischaemic vs. ischaemic HFREF
- Glycaemic markers and HF subtypes
- Predicting survival after fully magnetically levitated LVAD implantation